Navigation Links
Masimo Reports Fourth Quarter and Full Year 2010 Financial Results; Provides 2011 Guidance
Date:2/15/2011

venue, royalty revenue and product revenue, including rainbow revenue, and GAAP earnings per share for the full fiscal year 2011.  These forward-looking statements are based on management's current expectations and beliefs and are subject to uncertainties and factors, all of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to: our dependence on Masimo SET and Masimo rainbow SET products and technologies for substantially all of our revenue; any failure in protecting our intellectual property exposure to competitors' assertions of intellectual property claims; the highly competitive nature of the markets in which we sell our products and technologies; any failure to continue developing innovative products and technologies; the lack of acceptance of any of our current or future products and technologies; obtaining regulatory approval of our current and future products and technologies; the risk that the implementation of our international realignment will not continue to produce anticipated operational and financial benefits, including a continued lower effective tax rate; the loss of our customers; the failure to retain and recruit senior management; product liability claims exposure; a failure to obtain expected returns from the amount of intangible assets we have recorded; the maintenance of our brand; the impact of the decline in the worldwide credit markets on us and our customers; the amount and type of equity awards that we may grant to employees and service providers in the future; and other factors discussed in the "Risk Factors" section of our most recent periodic reports filed with the Securities and Exchange Commission ("SEC"), which you may obtain for free on the SEC's website at www.sec.gov. Although we believe that
'/>"/>
SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring
2. Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors
3. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
4. Masimo to Report Fourth Quarter and Full Year 2010 Financial Results After Market Close on February 15, 2011
5. Masimo to Present at 29th Annual J.P. Morgan Healthcare Conference
6. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
7. Masimo to Present at Piper Jaffray 22nd Annual Healthcare Conference
8. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
9. BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
10. Masimo to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11. Masimo Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... President and Chief Executive Officer, will present a corporate ... Anthera will present at 4:30PM ET, ... New York City . ... a biopharmaceutical company focused on developing and commercializing products ...
(Date:11/22/2014)... Pennsylvania , 21 de noviembre de 2014 ... de ensayos clínicos externalizados y tecnologías eClinical, ha ... aproximación de ,seguimiento inteligente, para el seguimiento basado ... seguimiento inteligente amplía el concepto del seguimiento basado ... reducción de las visitas de seguimiento o cambio ...
(Date:11/22/2014)... Research and Markets  has announced the addition of the ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... market has been expanding rapidly owing to the improvement ... 2005-2013, sales of recombinant protein drugs available in Chinese ... it is projected that China ...
Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... A 9-year-old boy is now home safe and sound ... the way home from school thanks to the quick thinking ... device called EmSeeQ® by EmFinders that can quickly locate missing ... purchased the EmSeeQ bracelet in October for her son, Jakob, ...
... 2011 Generex Biotechnology Corporation (OTCBB: GNBT) ( ... into a binding letter agreement to license its ... Inc. ( www.amarantus.com ), a California-based biotechnology company, ... exchange for a non-refundable license fee of $10 ...
Cached Medicine Technology:EmSeeQ® Locator Device Aids in Returning Lost Spokane Boy with Autism Safely Back Home in Minutes 2EmSeeQ® Locator Device Aids in Returning Lost Spokane Boy with Autism Safely Back Home in Minutes 3Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 2Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 3Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 4Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 5
(Date:11/24/2014)... 2014 Mental health issues affect ... break up families, ruin careers, and generally destroy ... those that suffer,” says Hardy Nutritionals® ... that our specialized nutritional treatments can reverse these ... “Mind Over Matter”, the premiere episode of O2 ...
(Date:11/24/2014)... 24, 2014 SafeHandles™ announced that they ... with Ed Begley Jr, airing via Discovery Channel. Dates ... provide a passive, non-invasive, replaceable, and affordable germ protective ... custom-fit shrinkable sleeves and adhesives to promote hand hygiene ... the core of SafeHandles is the desire to make ...
(Date:11/24/2014)... 24, 2014 Gersowitz Libo & Korek, P.C., ... received national Tier recognition in the 2015 Edition of U.S. ... ranking signals a unique combination of quality law practice and ... receive this honor and especially grateful to our clients whose ... and ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
(Date:11/23/2014)... a well-known wedding dress manufacturer, has unveiled its new collection ... now offered at deeply discounted prices, up to 75 percent ... 15. The main purpose of the promotion is to expand ... are ideal options for ladies who are eager to look ... new mint cocktail dresses are very beautiful; they are made ...
Breaking Medicine News(10 mins):Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2
... of ,Medicare for ... All, or Single-payer Healthcare, OAKLAND, Calif., May 1 With ... a new field poll,this week illustrates that Californians will once again ... registered,nurses., A poll this week by the influential Field Institute ...
... of high blood pressure-related deaths occur in poorer ... -- Roughly 80 percent of high blood pressure-related deaths ... study by New Zealand researchers shows. , Once regarded ... pressure is now a global problem that affects both ...
... (May 2, 2008) SAGE, the worlds fifth largest journals ... and the NASN Newsletter for the National Association of ... a forum for advancing the specialty of school nursing, ... the health of children in school. Published bi-monthly, it ...
... ... May 1 Cephalon, Inc. (Nasdaq:,CEPH) today reported first quarter ... for the first quarter 2007 and the company,s,sales guidance of ... quarter was $0.57. Excluding amortization expense and certain other,items, basic ...
... more likely to make up lost slumber during day ... with sleep problems, pain, diabetes and respiratory problems are ... U.S. study finds. , Researchers from Vanderbilt University Medical ... age 80.1 years, who were monitored for an average ...
... in the United States, Canada, Sweden, and Norway ... of insulin-producing islets in adults with difficult-to-control type ... the National Institutes of Health (NIH), will determine ... lead to improved, long-lasting control of blood glucose ...
Cached Medicine News:Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 2Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 3Health News:Hypertension Takes Huge Toll in Developing Countries 2Health News:The National Association of School Nurses selects SAGE to publish its journal 2Health News:Cephalon Reports Strong First Quarter Earnings 2Health News:Cephalon Reports Strong First Quarter Earnings 3Health News:Cephalon Reports Strong First Quarter Earnings 4Health News:Cephalon Reports Strong First Quarter Earnings 5Health News:Cephalon Reports Strong First Quarter Earnings 6Health News:Cephalon Reports Strong First Quarter Earnings 7Health News:Cephalon Reports Strong First Quarter Earnings 8Health News:Cephalon Reports Strong First Quarter Earnings 9Health News:Cephalon Reports Strong First Quarter Earnings 10Health News:Cephalon Reports Strong First Quarter Earnings 11Health News:Cephalon Reports Strong First Quarter Earnings 12Health News:Napping Habits Tied to Sleep Disorders 2Health News:Studies test new approaches to islet transplantation 2Health News:Studies test new approaches to islet transplantation 3Health News:Studies test new approaches to islet transplantation 4
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers....
Lyphochek Hypertension Markers Control is a trilevel control designed to monitor the performance of testing procedures for renin and other analytes associated with hypertension disorders....
... Plus Control is a liquid ... today's busy immunoassay laboratory. With ... human serum based control can ... control products for immunoassay and ...
The Acceava hCG Combo test provides superior performance for the diagnosis of pregnancy with a simple procedure that provides easy to read black on white results in 3 minutes for urine or 5 minutes f...
Medicine Products: